查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1877442

分子膠分解劑市場：按類型、給藥方式、最終用戶、應用、國家和地區分類－全球產業分析、市場規模、市場佔有率及2025-2032年預測

Molecular Glue Degradation Agent Market, By Type, By Delivery Method, By End User, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 389 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年分子膠分解劑市場規模為 4.02 億美元，2025 年至 2032 年複合年成長率為 8.6%。

分子膠分解劑市場是標靶蛋白分解 (TPD) 療法的新興領域，該療法利用分子膠——一種能誘導目標蛋白與 E3 泛素連接酶接近的小分子——來實現選擇性蛋白質分解。分子膠分解劑市場正快速擴張，其驅動力在於對能夠分解以往「不可成藥」蛋白的療法的需求日益成長，尤其是在腫瘤學和罕見疾病領域。一個主要的市場趨勢是人工智慧平台和基於結構的藥物設計工具的快速應用，這加速了新型分子膠分解劑的發現。然而，阻礙商業化進程的一大挑戰是監管政策不明朗，以及早期研發階段難以預測標靶選擇性和脫靶效應。儘管如此，分子膠的應用前景依然廣闊，可望拓展至癌症以外的神經退化性疾病、發炎性疾病和代謝性疾病等領域，在這些領域，標靶蛋白分解可望帶來首創的治療突破。

分子膠分解劑市場－市場動態

對永續製造日益成長的需求推動市場成長

隨著製藥公司將環境友善藥物研發置於優先地位，對永續生產的需求日益成長，這成為分子膠分解劑市場的重要成長驅動力。分子膠能夠利用小而高效的分子進行標靶蛋白質分解，進而助力實現永續發展目標。與傳統方法相比，分子膠所需的原料較少，合成步驟較簡單，產生的化學廢棄物也較少。隨著全球減少製藥生產環境足跡的壓力不斷增大，製造商正在加速採用更環保的化學技術和節能的研發平台。策略性的產業合作也進一步強化了這個趨勢。例如，2024年5月，武田製藥與Degron Therapeutics簽署了一項價值高達12億美元的授權協議，共同開發可擴展的分子膠分解劑，這反映了市場正朝著更永續、資源更高效的治療方案轉變。預計這一永續發展趨勢將在未來幾年推動市場成長。

分子膠分解劑市場區隔分析：

全球市場按類型、交付方式、最終用戶、應用程式和地區進行細分。

基於終端用戶細分，製藥公司是全球分子膠分解劑市場中最重要的類別之一，因為它們推動了新型標靶療法的臨床開發和商業化。分子膠，例如 PROTAC 和 LYTAC，因其選擇性分解致病蛋白的能力而受到越來越多的研究，使其成為新型藥物研發管線的理想選擇。例如，2024 年 12 月，Monte Rosa Therapeutics 公司報告稱，其 MRT-2359 I/II 期臨床試驗的劑量遞增階段顯示，在接受過大量預處理的實體瘤患者中，採用 21 天用藥、7 天停藥的給藥方案，該藥物具有良好的安全性，並能有效分解 GSPT1。預計將於 2025 年第一季公佈更多臨床資料，包括生物標記和活性訊息，凸顯了製藥和生物技術產業在靶向蛋白分解方面取得的持續進展。

根據類型分類，蛋白水解靶向嵌合體（PROTAC樣）是分子膠分解劑市場的重要組成部分，因為它能夠選擇性地募集E3泛素連接酶來分解致病蛋白，從而為以往「不可成藥」的靶點提供了一種強力的解決方案。業界活躍的研發活動，例如Monte Rosa Therapeutics在分子膠分解劑領域的進展，凸顯了其重要性。 2025年4月，該公司公佈了臨床前資料，證明其CDK2標靶分解劑MRT-51443與現有療法聯合使用時，能夠改善HR陽性/HER2陰性乳癌模型中的腫瘤消退。 Monte Rosa在2025年的產品線更新中也重點介紹了即將提交的IND申請，包括用於分解NEK7的MRT-8102以及實體瘤候選藥物MRT-2359的持續研發。 Monte Rosa於2024年底與諾華達成重大合作，其中包括1.5億美元的首付款以及超過20億美元的潛在里程碑付款，用於其VAV1靶向膠水分解劑的研發，這凸顯了該細分市場的商業價值。這些進展共同表明，PROTAC類細分市場是分子膠水分解生態系統中高價值的成長引擎。

分子膠分解劑市場—地域性洞察

北美市場以對生物技術和製藥研發的大量投資為特徵，這得益於其完善的基礎設施以及眾多領先的研究機構和公司。同時，中東和非洲市場呈現多元化格局，醫療保健體系的改善和生命科學領域的投資推動了市場成長。拉丁美洲市場也在逐步擴張，對生物製藥開發和合作的興趣日益濃厚，為生物技術進步創造了有利環境。地域分類凸顯了不同地區在成熟度、投資水準和監管環境方面的差異，這些因素對分子膠分解劑的全球市場動態產生了重大影響。

美國分子膠分解劑市場—國家概況

美國憑藉其強大的生物技術生態系統、先進的研究基礎設施以及對新一代標靶蛋白分解技術的快速應用，成為北美分子膠分解劑市場最重要的國家。美國擁有眾多領先的製藥創新者、頂尖的學術研究機構以及密集的臨床試驗中心網路，這使得分子膠概念能夠更快地轉化為臨床階段的治療藥物。此外，美國受益於FDA對突破性療法的支持性核准途徑和強勁的風險投資，這兩方面都加速了市場擴張。這種領先地位體現在許多發展案例中，例如艾伯維（AbbVie）於2025年1月與Neomorph的合作，後者獲得了高達16.4億美元的資金，用於推進分子膠分解劑在腫瘤學和免疫學領域的應用——這表明美國主導的合作和資金投入正在塑造分子膠技術的全球發展軌跡。

分子膠分解劑市場－競爭格局：

分子膠分解劑市場競爭異常激烈，其發展主要受標靶蛋白分解技術的創新和策略合作的推動。作為PROTAC和分子膠技術的先驅，Arvinas已將多個候選藥物推進至腫瘤及其他領域的臨床試驗階段。 Kymera Therapeutics以其專有的E3連接酶靶向平台以及與吉利德和其他製藥公司在開發新型分子膠方面開展的卓有成效的合作而聞名。 C4 Therapeutics也利用其整合的BiDAC和MonoDAC平台加速分子膠分解劑的發現和臨床開發。這些公司以及AbbVie和Genentech等其他創新企業，正透過技術領先、產品線推進和策略聯盟重塑市場競爭格局，使其處於這個快速變化的市場的前沿。

目錄

第1章：分子膠分解劑市場概述

  • 研究範圍
  • 市場估算年份

第2章：執行概要

  • 市集
    • 分子膠分解劑市場概覽（按類型分類）
    • 分子膠分解劑市場概況（依給藥方式分類）
    • 分子膠分解劑市場按最終用戶分類的概況
    • 分子膠分解劑市場按應用領域分類的概況
    • 各國分子膠分解劑市場概況
    • 分子膠分解劑市場區域概覽
  • 競爭洞察

第3章：分子膠分解劑市場主要趨勢

  • 分子膠分解劑市場促進因素
    • 市場促進因素的影響分析
  • 分子膠分解劑市場限制因素
    • 市場限制因素的影響分析
  • 分子膠分解劑市場機遇
  • 分子膠分解劑市場未來趨勢

第4章：分子膠分解劑產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景分析
  • 規範架構分析

第5章：分子膠分解劑市場：地緣政治緊張局勢升級的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：分子膠分解劑市場概況

  • 分子膠分解劑市佔率分析，2024年
  • 主要製造商細分數據
    • 知名球員分析
    • 新興參與者分析

第7章：分子膠分解劑市場－按類型分類

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 溶小體靶向嵌合體
    • 蛋白水解靶向嵌合體
    • 其他

第8章：分子膠分解劑市場－依給藥方式分類

  • 概述
    • 按交付方式分類的細分市場佔有率分析
    • 口服
    • 注射劑

第9章：分子膠分解劑市場－以最終用戶分類

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 製藥公司
    • 學術和研究機構
    • 生技公司

第10章：分子膠分解劑市場－依應用領域分類

  • 概述
    • 按交付方式分類的細分市場佔有率分析
    • 消費性電子產品
    • 汽車
    • 電信和數據通訊
    • 能源與電力
    • 工業的
    • 其他

第11章：分子膠分解劑市場－依地域分類

  • 介紹
    • 按地域分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美分子膠分解劑主要生產商
    • 北美市場規模及預測（按國家/地區分類）
    • 北美市場規模及預測（按類型分類）
    • 北美市場規模及預測（以交付方式分類）
    • 北美市場規模及預測（依最終用戶分類）
    • 北美市場規模及預測（按應用分類）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲分子膠分解劑主要生產商
    • 歐洲市場規模及預測（按國家/地區分類）
    • 歐洲市場規模及預測（按類型分類）
    • 歐洲市場規模及預測（以交付方式分類）
    • 歐洲市場規模及預測（依最終用戶分類）
    • 歐洲市場規模及預測（按應用領域分類）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區
    • 概述
    • 亞太地區分子膠分解劑主要生產商
    • 亞太市場規模及預測（依國家/地區分類）
    • 亞太市場規模及預測（按類型分類）
    • 亞太市場規模及預測（以交付方式分類）
    • 亞太市場規模及預測（依最終用戶分類）
    • 亞太市場規模及預測（按應用分類）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲分子膠分解劑主要生產商
    • 拉丁美洲市場規模及預測（按國家/地區分類）
    • 拉丁美洲市場規模及預測（按類型分類）
    • 拉丁美洲市場規模及預測（以交付方式分類）
    • 拉丁美洲市場規模及預測（按最終用戶分類）
    • 拉丁美洲市場規模及預測（按應用分類）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲分子膠分解劑主要生產商
    • MEA市場規模及預測（依國家/地區分類）
    • MEA市場規模及預測（按類型分類）
    • 中東和非洲市場規模及預測（以交付方式分類）
    • MEA市場規模及預測（依最終用戶分類）
    • MEA市場規模及預測（依應用分類）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 中東和非洲其他地區

第12章：主要供應商分析－分子膠分解劑產業

  • 競爭基準化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司簡介
    • Arvinas
    • Jiangsu Chia Tai-Tianqing
    • Nanjing Shunxin
    • C4 Therapeutics
    • AbbVie
    • Venquis Therapeutics
    • Monte Rosa Therapeutics
    • Qilu Pharmaceutical
    • Kymera Therapeutics
    • Genentech (Roche)
    • Takeda Pharmaceuticals
    • Eli Lilly and Company
    • Bristol-Myers Squibb
    • Pfizer
    • Gilead Sciences
    • Hansoh
    • Beijing SL
    • Yangtze River

第13章：360度AnalystView

第14章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5753

The Molecular Glue Degradation Agent Market size was valued at US$ 402 Million in 2024, expanding at a CAGR 8.6% from 2025 to 2032.

The Molecular Glue Degradation Agent Market is an emerging segment of targeted protein degradation (TPD) therapies that use molecular glues-small molecules that induce proximity between a target protein and an E3 ubiquitin ligase, resulting in selective protein degradation. The Molecular Glue Degradation Agent Market is expanding rapidly, driven by the growing demand for therapies capable of degrading previously "undruggable" proteins, particularly in oncology and rare diseases. A major market trend is the rapid adoption of AI-enabled platforms and structure-based design tools, which accelerate the discovery of novel molecular glue degraders. However, a significant challenge to faster commercial progress is a lack of regulatory clarity, as well as the difficulty of predicting target selectivity and off-target effects in early development. Despite this, there is a significant opportunity to expand molecular glue applications beyond cancer to include neurodegenerative, inflammatory, and metabolic disorders, where targeted protein degradation could lead to first-in-class therapeutic breakthroughs.

Molecular Glue Degradation Agent Market- Market Dynamics

Growing Demand for Sustainable Manufacturing Propels Market Growth

The rising demand for sustainable manufacturing is a significant growth driver in the Molecular Glue Degradation Agent market, as pharmaceutical companies prioritize environmentally responsible drug development. Molecular glues contribute to sustainability goals by allowing for targeted protein degradation using small, efficient molecules that require fewer raw materials, have simpler synthesis steps, and produce less chemical waste than traditional approaches. As global pressure grows to reduce pharmaceutical production's environmental footprint, manufacturers are accelerating the use of greener chemistry and energy-efficient development platforms. Strategic industry collaborations help to reinforce this trend. For instance, in May 2024, Takeda Pharmaceuticals signed a licensing agreement with Degron Therapeutics worth up to USD 1.2 billion to develop scalable molecular glue degraders, reflecting the market's shift toward more sustainable and resource-efficient therapeutic solutions. This sustainable trend is expected to drive market growth in the coming years.

Molecular Glue Degradation Agent Market- Segmentation Analysis:

The worldwide market is segmented on the basis of Type, Delivery Method, End User, Application, and Region.

Based End-User segmentation, the pharmaceutical company's segment is one of the most important categories in the Global Molecular Glue Degradation Agent Market because they drive clinical development and commercialization of new targeted therapies. Molecular glues, such as PROTACs and LYTACs, are increasingly being studied for their ability to selectively degrade disease-causing proteins, making them ideal for novel drug pipelines. For instance, In December 2024, Monte Rosa Therapeutics reported that the dose-escalation phase of its Phase I/II trial of MRT-2359 demonstrated a favorable safety profile and effective GSPT1 degradation using a 21-day-on, 7-day-off dosing regimen in heavily pretreated solid tumor patients. Further clinical data, including biomarker and activity insights, are expected in Q1 2025, highlighting ongoing progress in targeted protein degradation in the pharmaceutical and biotechnology industries.

Based on Type segment, The Proteolytic Targeting Chimeras (PROTAC-like) segment is an important component in the Molecular Glue Degradation Agent Market because it allows for the selective recruitment of E3 ubiquitin ligases to degrade pathogenic proteins, providing a powerful solution for previously "undruggable" targets. Its significance is underscored by robust industry activity, such as Monte Rosa Therapeutics' advances in molecular glue degraders. In April 2025, the company presented preclinical data demonstrating that its CDK2-directed degrader MRT-51443 improved tumor regression in HR-positive/HER2-negative breast cancer models when combined with existing therapies. Monte Rosa's 2025 pipeline update also highlighted upcoming IND submissions, including MRT-8102 for NEK7 degradation and the continued development of solid-tumor candidate MRT-2359. Monte Rosa's major partnership with Novartis in late 2024, which included a $150 million upfront payment and potential milestones exceeding $2 billion for its VAV1-targeted glue degraders, underscores the segment's commercial relevance. These developments collectively highlight the PROTAC-like segment as a high-value growth engine in the molecular glue degradation ecosystem.

Molecular Glue Degradation Agent Market- Geographical Insights

North America's market is distinguished by significant investments in biotechnology and pharmaceutical research, which are supported by a robust infrastructure and a concentration of leading research institutions and companies. Meanwhile, the Middle East and Africa offer a diverse market landscape, with growth opportunities driven by improved healthcare systems and investments in life sciences. Finally, Latin America is gradually expanding, with increased interest in biopharmaceutical development and collaborations creating an enabling environment for biotechnology advancement. The geographical segmentation highlights varying degrees of maturation, investment, and regulatory environments, which have a significant impact on global market dynamics for molecular glue degradation agents.

United States Molecular Glue Degradation Agent Market- Country Insights

The United States is the most important country in the North American Molecular Glue Degradation Agent Market due to its robust biotech ecosystem, advanced research infrastructure, and rapid adoption of next-generation targeted protein degradation technologies. The country is home to leading pharmaceutical innovators, top academic research institutions, and a dense network of clinical trial sites, allowing for faster translation of molecular glue concepts into clinical-stage therapeutics. Furthermore, the United States benefits from supportive FDA pathways for breakthrough therapies and robust venture capital investment, both of which accelerate market expansion. This leadership is evident in developments such as AbbVie's January 2025 collaboration with Neomorph, in which the biotech received up to USD 1.64 billion to advance molecular glue degraders in oncology and immunology-demonstrating how U.S.-led partnerships and funding commitments are shaping the global trajectory of molecular glue technologies.

Molecular Glue Degradation Agent Market- Competitive Landscape:

The Molecular Glue Degradation Agent market is highly competitive, driven by innovation in targeted protein degradation and strategic collaborations. Arvinas, a pioneer in PROTAC and molecular glue technologies, has advanced multiple candidates to clinical trials in oncology and other areas. Kymera Therapeutics is well-known for its proprietary E3 ligase-targeting platforms and lucrative collaborations with Gilead and other pharmaceutical companies to develop novel molecular glues. C4 Therapeutics also uses its integrated BiDAC and MonoDAC platforms to accelerate the discovery and clinical development of molecular glue degraders. These companies, along with other innovators such as AbbVie and Genentech, are shaping the competitive landscape through technological leadership, pipeline advancement, and strategic alliances, putting them at the forefront of this rapidly changing market.

Recent Developments:

In March 2025, Magnet Biomedicine has formed a collaboration and licensing agreement with Eli Lilly to identify, develop, and market oncology-focused molecular glue therapies.

In January 2025, AbbVie and Neomorph, Inc. announced a collaboration and licensing agreement to develop novel molecular glue degraders for oncology and immunology.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MOLECULAR GLUE DEGRADATION AGENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Arvinas
  • Jiangsu Chia Tai-Tianqing
  • Nanjing Shunxin
  • C4 Therapeutics
  • AbbVie
  • Venquis Therapeutics
  • Monte Rosa Therapeutics
  • Qilu Pharmaceutical
  • Kymera Therapeutics
  • Genentech (Roche)
  • Takeda Pharmaceuticals
  • Eli Lilly and Company
  • Bristol-Myers Squibb
  • Pfizer
  • Gilead Sciences
  • Hansoh
  • Beijing SL
  • Yangtze River

GLOBAL MOLECULAR GLUE DEGRADATION AGENT MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Lysosome Targeting Chimeras
  • Proteolytic Targeting Chimeras
  • Others

GLOBAL MOLECULAR GLUE DEGRADATION AGENT MARKET, BY DELIVERY METHOD- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Injectable

GLOBAL MOLECULAR GLUE DEGRADATION AGENT MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Academic and Research Institutions
  • Biotechnology Firms

GLOBAL MOLECULAR GLUE DEGRADATION AGENT MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Consumer Electronics
  • Automotive
  • Telecom & Datacom
  • Energy & Power
  • Industrial
  • Others

GLOBAL MOLECULAR GLUE DEGRADATION AGENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Molecular Glue Degradation Agent Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Molecular Glue Degradation Agent Market Snippet by Type
    • 2.1.2. Molecular Glue Degradation Agent Market Snippet by Delivery Method
    • 2.1.3. Molecular Glue Degradation Agent Market Snippet by End User
    • 2.1.4. Molecular Glue Degradation Agent Market Snippet by Application
    • 2.1.5. Molecular Glue Degradation Agent Market Snippet by Country
    • 2.1.6. Molecular Glue Degradation Agent Market Snippet by Region
  • 2.2. Competitive Insights

3. Molecular Glue Degradation Agent Key Market Trends

  • 3.1. Molecular Glue Degradation Agent Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Molecular Glue Degradation Agent Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Molecular Glue Degradation Agent Market Opportunities
  • 3.4. Molecular Glue Degradation Agent Market Future Trends

4. Molecular Glue Degradation Agent Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Molecular Glue Degradation Agent Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Molecular Glue Degradation Agent Market Landscape

  • 6.1. Molecular Glue Degradation Agent Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Molecular Glue Degradation Agent Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Lysosome Targeting Chimeras
    • 7.1.3. Proteolytic Targeting Chimeras
    • 7.1.4. Others

8. Molecular Glue Degradation Agent Market - By Delivery Method

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Delivery Method, 2024 & 2032 (%)
    • 8.1.2. Oral
    • 8.1.3. Injectable

9. Molecular Glue Degradation Agent Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Pharmaceutical Companies
    • 9.1.3. Academic and Research Institutions
    • 9.1.4. Biotechnology Firms

10. Molecular Glue Degradation Agent Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Delivery Method, 2024 & 2032 (%)
    • 10.1.2. Consumer Electronics
    • 10.1.3. Automotive
    • 10.1.4. Telecom & Datacom
    • 10.1.5. Energy & Power
    • 10.1.6. Industrial
    • 10.1.7. Others

11. Molecular Glue Degradation Agent Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Molecular Glue Degradation Agent Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Molecular Glue Degradation Agent Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Molecular Glue Degradation Agent Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Molecular Glue Degradation Agent Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Molecular Glue Degradation Agent Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Molecular Glue Degradation Agent Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Arvinas
    • 12.2.2. Jiangsu Chia Tai-Tianqing
    • 12.2.3. Nanjing Shunxin
    • 12.2.4. C4 Therapeutics
    • 12.2.5. AbbVie
    • 12.2.6. Venquis Therapeutics
    • 12.2.7. Monte Rosa Therapeutics
    • 12.2.8. Qilu Pharmaceutical
    • 12.2.9. Kymera Therapeutics
    • 12.2.10. Genentech (Roche)
    • 12.2.11. Takeda Pharmaceuticals
    • 12.2.12. Eli Lilly and Company
    • 12.2.13. Bristol-Myers Squibb
    • 12.2.14. Pfizer
    • 12.2.15. Gilead Sciences
    • 12.2.16. Hansoh
    • 12.2.17. Beijing SL
    • 12.2.18. Yangtze River

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us